Michael Hauptmann

Title:	Prof. Dr. rer. nat.
Denomination:	Biostatistics and Registry Research
Current position:	Leiter Institut für Biometrie und Registerforschung
Specialist field:	Biometrie und Registerforschung
Office address:	Institut für Biometrie und Registerforschung Medizinische Hochschule Brandenburg Campus Neuruppin, Haus O Fehrbelliner Str. 38 16816 Neuruppin UND ZKS-BB - Zentrum für klinische Studien / Medizinische Hochschule Brandenburg Fehrbelliner Straße 38 16816 Neuruppin
Office phone number:	+49 3391 39-14 580
Office email:	michael.hauptmann@mhb-fontane.de

At MHB since:	09.04.2019
Research:	Statistic Methods, Registry Research
Teaching area(s):	Biometrie, Statistics
Expertise in:	Biostatistik, Studiendesign, statistische Methoden

Curriculum Vitae

Michael Hauptmann received a Ph.D. in Statistics from the University of Dortmund (Germany) in 1999. In the same year, he joined the Biostatistics Branch of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute in Bethesda, Maryland (USA), as a postdoctoral fellow, and became a tenure-track investigator in 2004. From 2006 to 2019, Michael Hauptmann was a senior statistician and head of the Biostatistics group at the Netherlands Cancer Institute in Amsterdam (The Netherlands). Since 2019, Michael Hauptmann is a professor of Biostatistics and Registry Research at the Brandenburg Medical School in Neuruppin, Germany. Michael Hauptmann has published over 180 peer-reviewed scientific articles. He is a Statistical Editor for the Journal of the National Cancer Institute and for Cancer Epidemiology. He is alos a member of the International Commission on Radiological Protection and the German Strahlenschutzkommission. For a complete CV, click here.

Since 2019 Professor of Biostatistics and Registry Research

Brandenburg Medical School

2011-2019 Group Leader Biostatistics

Netherlands Cancer Institute, Amsterdam

2004-2006 Principal Investigator

National Cancer Institute, Bethesda, Maryland, USA

1995-1999 PhD Student (degree awarded by University of Dortmund)

Helmholtz Center Munich

1990-1995 MSc Statistics

University of Dortmund

Publications

Meine besten 5 Publikationen:

Roberti S, van Leeuwen FE, Ronckers CM, Krul IM, de Vathaire F, Veres C, Diallo I, Janus CPM, Aleman BMP, Russell NS, Hauptmann M. Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors. J Natl Cancer Inst 2022; 114(9): 1270-1278. http://www.ncbi.nlm.nih.gov/pubmed/35771630?dopt=Citation.
Roberti S, van Leeuwen FE, Hauptmann M, Pfeiffer RM. Bias correction for estimates from linear excess relative risk models in small case-control studies. Stat Med 2021; 40(26): 5831-5852. http://www.ncbi.nlm.nih.gov/pubmed/34418146?dopt=Citation.
Hauptmann M, Daniels RD, Cardis E, Cullings HM, Kendall G, Laurier D, Linet MS, Little MP, Lubin JH, Preston DL, Richardson DB, Stram DO, Thierry-Chef I, Schubauer-Berigan MK, Gilbert ES, Berrington de Gonzalez A. Epidemiological Studies of Low-Dose Ionizing Radiation and Cancer: Summary Bias Assessment and Meta-Analysis. J Natl Cancer Inst Monogr 2020; 2020(56): 188-200. http://www.ncbi.nlm.nih.gov/pubmed/32657347?dopt=Citation.
Zavrakidis I, Jóźwiak K, Hauptmann M. Statistical analysis of longitudinal data on tumour growth in mice experiments. Sci Rep 2020; 10(1): 9143. http://www.ncbi.nlm.nih.gov/pubmed/32499558?dopt=Citation.
Beane Freeman LE, Blair A, Lubin JH, Stewart PA, Hayes RB, Hoover RN, Hauptmann M. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: the National Cancer Institute Cohort. J Natl Cancer Inst 2009; 101(10): 751-61. http://www.ncbi.nlm.nih.gov/pubmed/24478120?dopt=Citation.

Weitere/Alle Publikationen:
https://pubmed.ncbi.nlm.nih.gov/?term=Hauptmann+M&cauthor_id=35124703
https://www.ncbi.nlm.nih.gov/sites/myncbi/1Xcj2m4zh9CIYs/collections/60620094/public/